Your Health Plan:
Your Health Plan:
Not SelectedPRADAXA (dabigatran etexilate mesylate) is a brand-name prescription drug for treatment of Pulmonary Embolism, Cerebrovascular accident, Deep Vein Thrombosis and Pulmonary fat embolism. PRADAXA is a direct thrombin inhibitor. It is available in the form of oral capsule.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $200-240.
No saving program is found for PRADAXA.
Other alternatives to PRADAXA may include:
